Status:

COMPLETED

Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population

Lead Sponsor:

Alcon Research

Conditions:

Aphakia

Corneal Astigmatism

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the clinical performance of the ACRYSOF® IQ PanOptix® Toric Trifocal intraocular lens (IOL) when implanted in the eye following cataract removal in an Asian po...

Detailed Description

Both eyes will be implanted with the PanOptix Toric Trifocal IOL. The eye with the highest astigmatism will be implanted first. The second eye will be implanted within 7-14 days of the first eye. Sub...

Eligibility Criteria

Inclusion

  • Key
  • Planned bilateral cataract removal followed by posterior chamber IOL implantation with PanOptix Toric (TFNT30, TFNT40, TFNT50, or TFNT60);
  • Calculated target residual refractive error within ±0.50 diopter (D) of emmetropia within the commercially available IOL Power Range in both operative eyes;
  • Preoperative regular corneal keratometric astigmatism with predicted residual refractive astigmatism ≤ 0.50 diopter (D) in both operative eyes;
  • Other protocol-defined inclusion criteria may apply.
  • Key

Exclusion

  • Preoperative irregular astigmatism;
  • Clinically significant corneal abnormalities;
  • Glaucoma;
  • History of or current retinal disease; anterior or posterior segment inflammation;
  • Other planned ocular surgical procedures including, but not limited to, limbal relaxing incision (LRI)/Astigmatic Keratotomy and laser-assisted in situ keratomileusis (LASIK);
  • Other protocol-defined exclusion criteria may apply.

Key Trial Info

Start Date :

November 16 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 17 2021

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT04528069

Start Date

November 16 2020

End Date

December 17 2021

Last Update

December 30 2022

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Alcon Investigator 8117

Campsie, New South Wales, Australia, 2194

2

Alcon Investigator 7678

Sydney, New South Wales, Australia, 2150

3

Alcon Investigator 7813

Footscray, Victoria, Australia, 3011

4

Alcon Investigator 8122

Saint Albans, Victoria, Australia, 3021

Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population | DecenTrialz